CLOS
GNMK

Compagnie Lombard Odier SCmA’s GenMark Diagnostics, Inc GNMK Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,700
Closed -$15K – 943
2016
Q2 		$15K Hold
1,700
– – ﹤0.01% 803
2016
Q1 		$9K Hold
1,700
– – ﹤0.01% 898
2015
Q4 		$13K Buy
+1,700
New +$13.1K ﹤0.01% 839

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Compagnie Lombard Odier SCmA's GNMK Position: Q3 2016 in Review

Compagnie Lombard Odier SCmA sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2016, closing a stake of 1,700 shares — an estimated $15K sold.

Compagnie Lombard Odier SCmA first reported a position in GNMK in Q4 2015 and held it in 3 quarters. The position peaked at $15K in Q2 2016. 91 funds tracked by Wall St. Rank hold GNMK as of Q3 2016.

  • Compagnie Lombard Odier SCmA reported no remaining GenMark Diagnostics, Inc position as of Q3 2016 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 1,700 GenMark Diagnostics, Inc shares in Q3 2016, an estimated $15K.
  • Compagnie Lombard Odier SCmA first reported a position in GenMark Diagnostics, Inc in Q4 2015 and held it in 3 quarters.
  • Compagnie Lombard Odier SCmA's GenMark Diagnostics, Inc position peaked at $15K in Q2 2016.
  • 91 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2016.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q3 2016, filed 14 Nov 2016.